$4.80
0.05 (+1.05%)
Pain Therapeutics, Inc. (PTIE)
CAPS Rating:
A biopharmaceutical company that develops novel drugs for pain management and oncology.
A biopharmaceutical company that develops novel drugs for pain management and oncology.